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1. Introduction
Research in the field of biosensors has enormously increased
over the recent years. Since the development of the first
biosensor by Clark in 1962, where an amperometric oxygen
electrode was immobilised with an enzyme (glucose oxidase),1
many efforts have been invested to create functional hybrid
systems. These functional hybrid systems often benefit from the
coupling of the unique recognition and signal-amplification
abilities of biological systems, that have been developed and
optimised during millions of years of evolution, with an
artificial man-made signal detection and amplification system.
Thus, the combination of knowledge in bio- and electro-
chemistry, solid-state and surface physics, bioengineering,
integrated circuit silicon technology and data processing offers
the possibility of a new generation of highly specific, sensitive,
selective and reliable micro (bio-)chemical sensors and sensor
arrays. Moreover, the rapid development of silicon technology
has stimulated the fabrication of miniaturised analytical systems
such as mTAS (micro total analysis system), ‘lab on chip’
sensors, electronic tongue devices and electronic noses.2–17
Among the variety of proposed concepts and different types
of biosensors, the integration of biologically active materials
together with an ISFET (ion-selective field-effect transistor) is
one of the most attractive approaches. The ISFET was invented
by Bergveld18 in 1970 and has been introduced as the first
miniaturised silicon-based chemical sensor. In spite of distinct
difficulties with regard to practical applications, the great
interest in ISFET-based biosensors, so-called biologically
modified field-effect transistors (BioFETs), has generated a
great number of publications, a flow that shows no sign of
diminishing. The reason therefore is that silicon-based field-
effect devices are currently being the basic structural element in
a new generation of micro biosensors; they provide a lot of
potential advantages such as small size and weight, fast
response, high reliability, low output impedance, the possibility
of automatic packaging at wafer level, on-chip integration of
biosensor arrays and a signal processing scheme with the future
prospect of low-cost mass production of portable microanalysis
systems; moreover, their possible field of applications reaches
from medicine, biotechnology and environmental monitoring
through food and drug industries to defence and security.
This paper gives a review of recent and significant advances
in the research and development of BioFETs. In planing this
review, we have chosen to focus mainly upon developments
occurring during the last six years (from 1995 to the end of
2001). A computer search of the Science Citation Index has
found that more than 400 publications concerning ISFETs and
BioFETs have appeared from January 1995 to December 2001,
indicating the intensity of research activities devoted to this
important task. This review is in general limited to journal
articles and usually does not include patents, conference
proceedings, reports or PhD theses. Some references to
important works reported prior to 1995 have also been added to
provide additional source material.
The review is organised as follows: The principles of the
ISFET and BioFET are described in section 2. Recent advances
in the development of various types of BioFETs are reviewed in
section 3. Here, some examples of current applications of
BioFETs are presented, too. Concluding points and future
prospects of BioFETs are discussed in section 4.
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2. BioFETs in general
2.1. Biosensor definition and nomenclature
A major driving force behind the significant increase of interest
and research in biosensors has been the attraction to utilise the
high specifity and sensitivity of biomolecules and living
biological systems for sensor function: ‘An electrochemical
biosensor is a self-contained integrated device, which is capable
of providing specific quantitative or semi-quantitative analyt-
ical information using a biological recognition element (bio-
chemical receptor) which is retained in direct spatial contact
with an electrochemical transduction element’.
This definition for an electrochemical biosensor was recently
recommended by an IUPAC (International Union of Pure and
Applied Chemistry) working group.19 Thus, biosensors repre-
sent functional hybrid systems, generally combining two basic
components connected in series, namely a biological (molec-
ular) recognition system and a physico-chemical transducer.
The recognition system is often also called the bioreceptor,
because in the natural chemical senses, the recognition
phenomenon is performed by a chemoreceptive cell. The
biosensor is usually constructed by attaching a biologically
sensitive material to a suitable transducing system.
Different types of biologically sensitive materials of various
complexity can be applied as recognition elements, including
either biological molecular species [(e.g., enzymes, multi-
enzyme systems, antibodies, antigens, proteins, or nucleic
acids] or living biological systems (e.g., cells, plants, tissue
slices, intact organs or whole organisms), which utilise
biochemical mechanisms for recognition. The overall biological
recognition system translates the information from the (bio-
)chemical domain, typically an analyte concentration, into a
chemical or physical signal (bio-)chemical response. As a result
of the specific molecular interaction, there is a change in one or
more physico-chemical parameters. This change may produce
ions, electrons, gasses, heat or light, etc. Then, these quantities
are converted into a quantifiable signal—mostly to an electrical
signal—by the transducer part, amplified, processed and
displayed in a suitable form.
Depending upon the mechanism of (bio-)chemical inter-
action between the receptor part of the biosensor and the
analyte, two basic types of biosensors can be distinguished:
biocatalytic sensors and biocomplexing or bioaffinity sensors.
Biocatalytic biosensors are the best known and studied
biosensors since the pioneering work of Clark et al.1 Analyte
concentrations detectable with biosensors can range from 1027
M for biocatalytic sensors to trace concentrations of smaller
than 10215 M for affinity sensors.20 Recently, a hybrid
configuration of a biosensor which combines the attributes of
both the high affinity binding and the amplification properties
of an enzyme has also been suggested.20 Due to their simple
principle of measurement and integratable signal processing on
chip, biosensors that are based on electrochemical transducer
principles are the most common sensor devices developed so
far. According to the official nomenclature, recommended by
IUPAC,19 electrochemical transducers include amperometric,
potentiometric, conductometric, impedimetric and semiconduc-
tor field-effect principles.
To obtain a general overview of biosensors (not only
electrochemically based, and specially FET-based sensors as in
this article), some excellent books and reviews are availa-
ble.19–56 For example, a general discussion of (bio-)chemical
and molecular aspects of biosensors as well as a survey of the
major types of biological molecules and systems (including
antibodies, enzymes and whole cells) for biosensors are
summarised in refs 19, 24, 37, 45 and 48. Transducer aspects of
biosensors are discussed (e.g. in refs 19, 20, 35, 46 and 47).
Biosensors and biochips in biological and medical diagnostics
are emphasised,27,48 environmental applications of biosensors
have been reviewed.47,49,50 A current development in bio-
sensors for toxic materials of defence interest is surveyed.51 The
design and placement of biosensors in microsystems as well as
microfabrication technologies for biosensors that are fully
compatible to microelectronic processing are discussed else-
where.36,53,54 The major barriers to successfully commercialise
biosensors for chemical processes, biotechnology and clinical
diagnostics as well as economic problems that accompany the
bringing onto the market have been critically assessed, (e.g. in
refs 55 and 56). Recommended definitions and classifications of
biosensors are discussed in ref. 19.
2.2. BioFET principle
In general, the ISFET represents the basic structural key
element that is mostly used for BioFETs, even if its ion-
sensitive properties are not necessary for the signal transduction
(for example, in affinity BioFETs or for the measurement of
action potentials of living cells). BioFETs can be simply
constructed from an ISFET by modifing the gate or coupling it
with different biological recognition elements as schematically
shown in Fig. 1. In these devices, the charge (or potential) effect
is used to transduce the recognising phenomena. The most
critical point in information transfer from the biological
recognition part to the transducer part is the interface between
these two domains.40 For a better understanding of the
functional principle of a BioFET, which utilises the semi-
conductor field-effect as the coupling mechanism between the
above mentioned two domains, the operating principle of the
ISFET is first outlined in the following and chemico-physical
phenomena underlying the ISFET transduction mechanism are
discussed.
At present, there exist numerous different ISFET structures
and processes for their fabrication, but the principle of using an
electric field to create regions of excess charge in a semi-
conductor substrate in order to enhance or diminish the local
conductivity is common to all of them. Reviews of various types
of ISFETs are presented in refs 57–63. In addition, there are
explicit recommendations that have been made about the
terminology and conventions for ISFET devices.64
The functionality of an ISFET can be explained by compar-
ing the sensor with a conventional IGFET (insulated-gate field-
effect transistor) or MOSFET (metal-oxide-semiconductor
field-effect transistor). The ISFET is then an IGFET, in which
the metal gate is replaced by an ion-sensitive membrane, an
electrolyte solution and a reference electrode. As one example,
Fig. 1 Schematic set-up and functional principle of a (bio-)chemical
sensor that is based on an ISFET, consisting of receptor, transducer and
signal processing.
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a typical construction of an n-channel ISFET is schematically
shown in Fig. 2. It consists of a p-type silicon substrate with two
n-doped regions, source and drain, separated by a short channel
that is covered by the gate insulator. Typically, the gate
insulator is a SiO2 layer or a double layer insulator of SiO2–
Si3N4, SiO2–Al2O3 or SiO2–Ta2O5. The upper layer of these
double insulator structures, i.e. Si3N4, Al2O3 and Ta2O5,
typically serve as sensitive materials for pH-sensitive ISFETs.
ISFETs that are selective towards other ions, so-called chem-
ically-sensitive FETs (ChemFET) can be obtained by means of
an additional surface modification of the gate insulator or by
deposition of subsequent specific membranes on top of the gate
insulator. Examples of such ChemFETs, for the determination
of K+, Ca2+, F2, etc., are described elsewhere.57–61,65–73
For operating an ISFET, the gate voltage, VG, is applied by a
reference electrode (e.g., Ag/AgCl electrode), which is also
responsible for fixing the potential of the test solution (analyte).
When a sufficiently positive bias potential is applied to the gate
(with respect to the bulk silicon substrate), an n-type inversion
layer is induced in the channel between source and drain. The
magnitude of the drain current, ID, will be determined by the
effective electrical resistance of the surface inversion layer and
the voltage, VDS, that is applied between source and drain. The
mechanism of operation of the ISFET can be described by the
processes (charge carrier distribution) which take place in each
phase and at the interfaces. Correspondingly, the drain current
of the ISFET, ID, can be deduced from that of an IGFET, by
simply adding the potential drops at the additional inter-
faces:58–60
ID = mCi(W/L)VD[VG2 (Eref2 o + csol2 (fSi/q) 2 (Qi + Qss)/
Ci 2 (QB/Ci) + 2ff) 2 0.5VD] (1)
where m is the electron mobility in the channel; W and L are the
width and the length of channel, respectively; Eref is the
potential of the reference electrode; fSi is the silicon electron
work function; q is the elementary charge; Ci is the capacitance
of the gate insulator; Qi, Qss and QB are the charges located in
the insulator, in the surface and interface states, and in the
depletion region, respectively; csol is the surface dipole
potential of the solution; ff is the potential difference between
the Fermi level of doped and intrinsic silicon; o is the potential
at the electrolyte–membrane interface that depends on the
activitiy of ions in the analyte. The potential o can be calculated
by the Nernst-Nikolsky equation or using a similar equation for
ISFETs with a solution–insulator interface. In the case of a pH-
sensitive ISFET, the gate insulator (typically Si3N4, Al2O3 or
Ta2O5) senses the H+-ion concentration, generating an interface
potential on the gate insulator. The pH response can be
explained by the so-called site-binding theory. This model
assumes that in contact with an aqueous solution, the surface of
the gate insulator hydrolyses into ionisable sites (e.g., OH
groups). These active sites are either able to bind or release
hydrogen ions in a dynamic exchange process. Thus, their
protonation state changes with the pH of the surrounding
analyte. According to the site-binding model, the pH depend-
ence of the interface potential analyte/pH-sensitive gate in-
sulator, o, is given by the following equation:20,60,61
o = 2.3(kT/q)[b/(b + 1)](pHpzc 2 pH) (2)
where pHpzc (point of zero charge) is the pH value for which o
= 0; k is the Boltzmann constant; T is the absolute temperature;
b is a parameter which reflects the chemical sensitivity of the
gate insulator and is dependent on the density of surface
hydroxyl groups and the surface reactivity (for a detailed
description of the ISFET operation principle, see refs 57–61, 74
and 75).
The resulting pH-dependent electrical surface charge of the
gate insulator leads to a modulation of the channel conductance
and, consequently the drain current, ID, of the ISFET. Thus, by
measuring changes in the drain current, the pH value of the test
solution can be determined quantitatively. In practice, ISFETs
are often operated in the so-called constant-charge (or constant
drain current) mode.58,64,76 In the constant-charge mode, by
setting the drain current at a fixed value using a feedback circuit,
the voltage shift that results from the (bio-)chemical reaction
can be recorded directly. The resulting sensor output signal is
then proportional to the voltage shift. The arrangement in the
constant-charge mode also allows a simultaneous multisensor
characterisation by using only one common reference elec-
trode.
Since the ISFET has been proved to be a sensor device that is
very sensitive for any kind of electrical interaction at or nearby
the gate insulator/electrolyte interface, in general, it will be
clear that nearly each (bio-)chemical reaction leading to
chemical or electrical changes at this interface can be measured
by means of an ISFET coupled with a bioreceptor. Therefore,
the following basic mechanisms of potential generation for
BioFETs can be considered: (i) potential changes that are
caused by a catalytic reaction product (e.g., between an enzyme
and its substrate), this product can be detected by an ISFET; (ii)
potential changes that are caused by surface polarisation effects
or the change of dipole moments (e.g., antigen–antibody
affinity reactions or DNA (deoxyribonucleic acid) hybrid-
isation, in principle, under certain conditions an ISFET is able
to detect the change of the electric field associated with affinity
binding of biomolecules; (iii) potential changes that are coming
from living biological systems as a result of more sophisticated
(bio-)chemical processes (e.g., action potential of nerve cells).
Considering all these aspects, BioFETs can be classified
according to the biorecognition element that is used for
detection. Based on the hierarchy of biological complexity, they
can be subdivided as depicted in Fig. 3: enzyme-modified FET
(EnFET); immunologically modified FET (ImmunoFET);
DNA-modified FET (DNA-FET or GenFET: gene-modified
Fig. 2 Structure of an ISFET. RE, reference electrode; VG, gate voltage;
VDS, drain-source voltage; ID, drain current. Fig. 3 Diagram of possible BioFET classification.
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FET); cell-based FET (or cell-potential FET (CPFET)); and
‘beetle/chip’ FET. In addition, ‘artificial’ BioFET-based bio-
chips can be designed, where ion channel receptor, binding
proteins, etc. are directly coupled to the microelectronic
component. However, the development of this last group is still
in progress.
Table 1 summarises major historical landmarks in the
development of the different types of BioFETs. Since starting
with the first concept of an ISFET in 1970 by Bergveld, it has
taken over 25 years to advantageously utilise ISFETs for a
direct DNA-hybridisation detection experiment.
3. Classification and advances in BioFETs
3.1 EnFET
Due to their specific binding capabilities as well as their
catalytic activity, enzymes are often chosen as bioreceptors. The
concept to design an EnFET, i.e. to combine enzymes with an
ISFET was first proposed in 1976 by Janata and Moss77 and was
realised in 1980 by Caras and Janata with a penicillin-sensitive
biosensor.78 Later, a multitude of ISFETs were developed with
the application of a wide variety of enzymes.57–61,84,85
EnFETs are usually constructed by immobilising an enzyme
onto the gate insulator of an ISFET. The most critical point of
the EnFET construction is the attachment of the enzyme or the
enzyme-containing layer to the underlying inorganic gate
insulator material of the FET. To immobilise enzymes, a
number of methods are currently discussed, which include
physical or chemical adsorption, entrapment within polymeric
matrices, covalent binding, cross-linking by bi-functional cross-
linking agents (mostly glutaraldehyde) and mixed physico-
chemical methods (entrapment and cross-linking).19,24,85–89
The simplest and most frequently used enzyme membrane
deposition methods are the drop-on technique and the spin-
coating or the dip-coating of a mounted sensor chip into an
enzyme solution. The very small amount of the sometimes
expensive enzyme needed for the device fabrication, can also be
considered to be an attractive feature in addition to other ISFET-
related advantages, like the small size (down to mm range), the
small sample volume (down to nl range), etc. To improve the
often quite poor adhesion between the transducer surface and
the enzyme-containing layer, a prior surface silanisation is
normally performed.
Generally, the working principle of an EnFET can be
explained in the following way: during the enzymatic reaction
of the enzyme with its substrate, either products are generated or
reactants are consumed, and this concentration change can be
monitored by the underlying ISFET. Hence, a corresponding
change of the ISFET signal can be correlated with the original
analyte concentration. As an example, Fig. 4 shows the structure
and the functional principle of a penicillin-sensitive EnFET.
The enzyme penicillinase catalyses the hydrolysis of penicillin
to penicilloic acid yielding a local pH change near the gate
region of the ISFET. Then, the output signal change will be
determined by the amount of penicillin in the sample solution.
Such an EnFET can be constructed, in principle, with any kind
of enzyme. The nature, however, provides only a limited
number of enzymes that are able to generate or consume
electrochemically active species, in particular protons as
required for EnFETs that are based on pH-sensitive ISFETs.
A wide range of EnFETs differing in their sensor design or
gate material, enzyme membrane composition or immobilisa-
tion method have been reported for the detection of the analytes
glucose, urea, penicillin, ethanol, lactose, sucrose, maltose,
ascorbic acid, lactate, acetylcholine, organophosphorus pesti-
cides, formaldehyde, creatinine, etc.43,84–132 Some recently
developed EnFETs are summarised in Table 2. With the
exception of a few papers on urea-sensitive EnFET based on
ammonia-108 or fluoride-sensitive ISFETs,128 most reported
EnFETs are built-up of pH-sensitive ISFETs, in which the
hydrogen ions are produced or consumed by the enzymatic
reaction. The most popular enzymes for EnFETs are glucose
oxidase, urease and penicillinase, because of their suitability as
model systems for EnFET studies, and because of their
important role for the detection of glucose, urea and penicillin in
many fields of application. The corresponding enzymatic
reactions are summarised in eqns (3)–(5):
(3)
(4)
Table 1 Major historical landmarks in the development of BioFET
devices
1970 Concept of an ISFET, first attempt to apply the ISFET in
neurophysiological measurements18
1976 Concept of the first BioFET (EnFET)77
1980 First realised EnFET78
1980 Concept of an ImmunoFET79
1981 Coupling cells with a MOSFET80
1991 First neuron-transistor (or CPFET)81
1997 ‘Beetle/chip’ BioFET82
1997 First experimental attempt of direct DNA-hybridisation
detection83
Fig. 4 Structure and principle of function of a penicillin-sensitive EnFET (PenFET). The enzyme penicillinase is immobilised on top of a pH-sensitive
ISFET with Ta2O5 as pH-sensitive gate insulator.
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In practice, for exact measurement of the test sample, a pH
ISFET/EnFET differential arrangement (Fig. 5) is often em-
ployed (see e.g., refs. 84,111 and 114), where the pH ISFET acts
as a reference system and is assembled in the same way as the
EnFET, but it contains a blank enzyme-free membrane.
Differential mode measurements have many advantages com-
pared to single EnFET measurements and allow an automatic
compensation of effects that are caused by some disturbing
factors such as pH variation of the bulk solution, temperature
variation, drift of the sensor output signal with the time, etc.
Thus, the differential output signal only depends on the
concentration of the analyte to be necessarily detected.
Moreover, in this case a strongly stable reference electrode is
not required. A gold or platinum metal can be used as a common
‘pseudo’ reference electrode, which can be simply integrated
onto the FET chip yielding a fully miniaturised biosensor.
Intensive efforts during recent years have focused on the
improvement of the working characteristics of EnFETs and on
solving problems, which actually prevent their commercial
development and limit the field of their practical use. These
problems include limitations related to the operating principle
of EnFETs, the semiconductor device itself as well as the
following technological factors: (i) the dependence of the sensor
response on buffer capacity, ionic strength and pH of the test
sample; (ii) the higher value of detection limit, restricted
dynamic range and non-linearity; (iii) the relatively slow
response and recovery times; (iv) the operating and storage
stability, the light sensitivity as well as reproducibility; (v) the
dependence on enzyme immobilisation and deposition meth-
ods; and (vi) the incompatibility of most used enzyme-
containing layer deposition and patterning methods with silicon
integrated circuit technology.
Recently, a number of technological solutions have been
proposed and tested to solve these drawbacks and to improve
the working characteristics of EnFETs. Some of these problems
can be removed or at least reduced by applying additional
charged polymeric membranes (e.g., Nafion or poly(4-vinylpyr-
idine-co-styrene)) on top of the enzyme membrane, which
control the substrate and product diffusion.93,100,103,104,113,115
Such approaches have been used in order to reduce the influence
of the buffer and salt concentration on the sensor response, to
extend the dynamic range and to increase the sensitivity of
glucose-93 and urea-sensitive103 EnFETs. However, this con-
cept is not universal. For instance, no improvement has been
achieved in the case of a penicillin-sensitive EnFET.113
Another design was introduced,133 where a pH-static urea-
sensitive EnFET was developed by keeping the pH of the
enzyme membrane at a constant, predetermined value using an
in situ coulometric titration of the enzymatic reaction products,
namely the H+ ions. In this case, the EnFET is able to linearly
measure the substrate concentration over an extended concen-
tration range, independent of the buffer capacity of the sample
solution.
An alternative principle has been suggested,90,92 where an
additional Pt electrode is deposited on the gate region of a
glucose-sensitive EnFET; the function of the Pt electrode is to
electrolyse hydrogen peroxide (i.e., the by-product of the
glucose oxidation reaction) and generate two additional hydro-
gen ions (see eqn. (5)). The sensitivity, dynamic range and
response time of the biosensor could be significiantly improved
in this way. Recently, the authors have also demonstrated an all-
solid-type ISFET glucose sensor with an integrated Ag/AgCl
reference electrode on the same chip.91
With the same background, a further EnFET99 utilises a
glucose oxidase membrane doped with manganese dioxide
(MnO2) powder that catalyses hydrogen peroxide. As a result,
the additional product oxygen is produced, which can be
recycled for the glucose oxidation reaction. In this way, the
dynamic range of glucose measurement was extended up to 20
mM. Hence, the developed EnFET with a high upper detection
limit can be in principle applied to the detection of glucose in
undiluted blood samples (the glucose concentration in human
blood is normally about 5 mM, reaching 20 mM and more for
diabetics).
The concept of in situ electrochemical generation of ions was
used96,97 in order to improve the recovery time of a glucose-
sensitive EnFET. After the response of the sensor, hydroxyl
ions (OH2) are generated in the enzyme membrane by applying
a reduction potential to an additional Pt electrode. As a result,
the recovery time of the presented glucose-sensitive EnFET was
reduced to less than two minutes.
To reduce the response time of BioFETs in95 different
EnFETs modified with a monolayer/multilayer enzyme have
been developed. The major advantage of these enzyme-thin-
layered sensors is their fast response time (e.g., ca. 10 s for the
urea-sensitive EnFET). This advantage over traditional thick-
polymer-based EnFETs results from the low diffusion barrier
for the substrate penetration to the biocatalytically active sites.
Disadvantages of the monolayer-modified EnFETs are the
relatively short lifetime and low stability.
A highly sensitive, low detection limit and long lifetime
penicillin-sensitive EnFET was developed109–112 by simple
Table 2 Recently developed EnFETs including the enzyme system used
and the analyte to be detected
Analyte Enzyme system
Glucose Glucose oxidase90-98,100,129,130
Glucose oxidase/MnO2 powder99
Glucose dehydrogenase101
Urea Urease87,95,101–108
Penicillin penicillinase109–113,115
Penicillin G acylase114
Sucrose Invertase/mutarotase/glucose oxidase92
Invertase/glucose dehydrogenase101,117
Maltose Maltase/glucose dehydrogenase101
Ethanol Alcoholdehydrogenase/aldehyde
dehydrogenase101
Lactose b-Galactosidase/glucose
dehydrogenase116
b-Galactosidase/galactose
dehydrogenase101
Ascorbic acid Peroxidase98,118
Creatinine Creatinine deiminase126
Formaldehyde Alcohol oxidase124,125
Acetylcholine Acetylcholinesterase95,119
Organophosphate compound
(paraoxon)
Organophosphate hydrolase122
Fluorine-containing
organophosphates
Organophophorus acid anhydrolase123
Fig. 5 pH ISFET/EnFET differential arrangement. The pH ISFET acts as
‘reference’ system; it is buit-up in the same way as the EnFET but without
immobilised enzyme membrane.
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adsorptive immobilisation of the enzyme penicillinase on a
Ta2O5-gate ISFET. As the EnFET works on the principle of pH
change caused by an enzymatic reaction, the sensitivity,
detection limit and linear range of the calibration curve of
EnFETs are mostly affected by pH, buffer solution and ion
concentration of the buffer solution. Higher penicillin sensitiv-
ity (about 120 mV mM21) and an extremely low detection limit
(5 mM) of an EnFET described in109–112 was achieved by using
an optimised low capacity polymix buffer solution.
A chemical grafting of enzyme molecules directly on the ion-
sensitive gate of an ISFET has been realised in108 for a urea-
sensitive EnFET. The influence of different technological
procedures of the enzyme immobilisation on the characteristics
of glucose-, urea- and cholinesterase-sensitive EnFETs have
been investigated.88
A number of attempts have been made to integrate several
EnFETs on a single chip or in a hybrid module. The main goal
of all these attempts is to obtain a miniature multiple EnFET
array that permits the measurements of several analyte concen-
trations sequentially or simultaneously. A multi-enzyme sensor
for the determination of glucose, ascorbic and citric acid by two
EnFETs was developed.98 Moreover, an EnFET array for the
detection of four analytes (urea, glucose, acetylcholine and N-
acetyl-L-tyrosine ethyl ester) has been reported.95 A multi
EnFET array integrated in a commercial FIA (flow-injection
analysis) system has been developed;101 this array enables the
simultaneous monitoring of glucose, maltose, sucrose, lactose,
ethanol and urea during the cultivation process in bio-
technology. However, the main problem with a multi EnFET
array is possible cross-sensitivity. Because of the close distance
between the enzyme membranes and the gates of the EnFETs in
an array, the local variations of the pH value caused by the
enzymatic reaction in a particular enzyme membrane can
influence the reaction rate in another membrane (different
enzymes usually have different pH optima) and thus, can
influence the output signal of another EnFET within the array.
This cross-sensitivity can be eliminated, for example, by means
of an optimisation of the pH value, favourable for all applied
enzymes,117 or by the use of an FIA system under an automatic
control with a proper carrier flow as well as a proper sequence
of the enzyme membranes.101
The existing methods for depositing enzyme-containing
layers on the FET transducers are mostly based on manual
techniques, which are relatively simple but time-consuming,
only poorly reproducible and incompatible with modern
integrated circuit technology. A basic form of EnFET, i.e. the
pH ISFET, is today a commercial reality (pH ISFETs are
available from Orion, Beckman, Sentron, Honeyweel, Chem-
FET Corporation, etc.)134 and produced by silicon integrated
technology. Therefore, for the fabrication of truly inexpensive
and thus disposable biosensors, it is of great interest to
manufacture the enzyme-containing layers also in batch
processes. Besides, multi-biosensors can be made by using
different masks. Recently, a number of fabrication techniques
for wafer-level deposition and patterning of enzyme-containing
layers have been developed. Possible methods include the
utilisation of photocurable polymers such as polyacrylamide105
or polyurethane acrylate,87,106 the lift-off technique,130 the
Langmuir-Blodgett technique and the ink-jet nozzle technique
for the localised deposition of individual enzyme membranes
(see also refs 39 and 84). A microcontact printing technique135
can also be advantageous for the deposition and patterning of
protein layers. These techniques permit the integration of the
enzymatic membrane fabrication into the whole ISFET fabrica-
tion process.
Another important aspect with regard to commercialisation
of EnFETs, is their encapsulation and packaging. Since
BioFETs, in particular EnFETs, work in electrolyte solution,
they require encapsulation only on selected parts of the device,
like bonding pads, bonding wires and silicon substrate, whereas
the sensitive part of the biosensors have to be left exposed to the
environment that they sense. However, this encapsulation and
packaging of EnFETs is exactly one of the most important and
critical steps in the complete fabrication process. For commer-
cial realisation, a full automatisation of the fabrication process
is necessary. It is thus very important to develop a wafer-level
encapsulation procedure that is compatible with conventional
silicon technology. Early proposed approaches on this subject
such as the use of anisotropic etching of Si, the Si on sapphire
structure, the rear-side contact-type ISFET, the rear-side gate-
type ISFET, etc., are reviewed in ref. 63. Recently, a wafer-level
packaging technique for ISFET-based biosensors (pH ISFET
and urea-sensitive EnFET) using a photocurable polyurethane
encapsulant formulation and a special thick film photo-
lithography approach has been realised in ref. 106. A novel
three-dimensional mesa ISFET was developed136 which sim-
plifies the encapsulation procedure and thus enables flat
packaging. A new method of fabrication of BioFETs based on
an Si-SiO2–Si structure was demonstrated by constructing a
glucose-sensitive EnFET.94 The required encapsulation of the
side walls and rear-side of the EnFET chip were carried out
during the ISFET fabrication process using SiO2, Si3N4 or
Ta2O5 films. Another concept to guarantee the solution-
resistant encapsulation has been proposed119 where an extended
gate (or separate gate) EnFET was built-up; this biosensor is
able to detect acetylcholine by using the enzyme acet-
ylcholinesterase. This structure has a lot of benefits such as
being simple in fabricating and packaging, being insensitive
towards light and being flexibile in the shape of the extended
gate area. This biosensor might be practical for application in
disposable multi-biosensors in the near future. Nevertheless, at
present, there is no unique and generally applicable encapsula-
tion and packaging method common for all BioFETs. In most
cases so far, encapsulation and packaging are still done by
hand.
With regard to possible practical applications, EnFETs were
utilised for the determination of glucose in blood serum100 and
urine,94 urea in blood serum102,104,107 and in hemodialysis
fluids.102 Moreover, an EnFET-based transcutaneous blood
glucose monitoring system has been realised and applied to
diabetic patients.129,130 The tested results could demonstrate the
feasibility of the developed biosensor system for individual
patients with various diabetic histories or diabetic complica-
tions. Another EnFET-based sensor system for the determina-
tion of creatinine in hemodialysis solutions and in serum of
renal failure patients was realised in ref. 126. As a further
approach in ref. 118 an ascorbic acid-sensitive EnFET for the
vitamin C determination in beverages is presented. Glucose,
maltose, sucrose, lactose, ethanol and urea concentrations were
monitored simultaneously during the cultivation of Escherichia
coli and Saccharomyces cerevisiae by means of an EnFET
array, which has been integrated in a commercial flow-injection
system.101 Penicillin-sensitive EnFETs were applied, namely
for the determination of penicillin G in penicillin fermentation
broths.114
Although EnFETs have a long history and much effort and
investment have been put into them, the transfer of EnFETs
from scientific laboratories to real life remains rather slow. Up
to now, no EnFET has been really commercialised for a wider
range of applications. Thus, a lot of work still remains to be
done to achieve a successful commercial product.
3.2. ImmunoFET
The high recognition ability of biological molecules is best
typified by an antibody–antigen interaction. An antibody is a
complex biomolecule consisting of hundreds of individual
amino acids arranged in a highly ordered sequence; the antigen
can be any macromolecule against which the antibody has been
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generated as a result of the defensive mechanism of the
organism known as the immune response. Proteins with
molecular weights greater than 5000 Daltons are generally
immunogenic,48 i.e. susceptible to being recognised and bound
by antibody with extremely high specificity. A minor chemical
modification of the molecular structure of the antigen can
dramatically lower its affinity towards the original antibody.
Thus, immunosensors may be useful for quantifying how well
the human immune system is functioning, and consequently
they can serve as excellent clinical diagnostic tools.
The possibility to directly monitor antibody–antigen inter-
actions, finding thus a simplified alternative to classical
immunoassays, has attracted many attempts to develop bio-
sensors in which the actual recognition takes place in a layer of
antibodies at the surface of the sensor (FET). Therefore, in this
review, attention will mostly be focused on the direct label-free
ImmunoFET. For indirect ImmunoFETs as well as for Im-
munoFET-based immunoenzymatic assays, where label mole-
cules such as enzymes are linked to antibodies or antigens in
order to carry detectable species to the sensor, see refs 137–142.
In addition, for the general aspects of immunosensors and
different engineering approaches see reviews refs 143–145.
A concept of direct immunosensing by an ISFET was
introduced by Schenck in 1978.79 In an ImmunoFET, which is
shown schematically in Fig. 6, the gate is modified by
immobilising antibodies or antigens (often in a membrane).
Since a FET basically represents a surface-charge measuring
device, and since antibodies and antigens (or more generally,
proteins) are mostly electrically charged molecules, it was
expected that the formation of an antibody–antigen complex on
the gate of an ISFET would lead to a detectable change in the
charge distribution and thus, directly modulate the drain current
of the ISFET. In this way, a unique possibility of direct
detection of immunological reactions by means of an Im-
munoFET could be obtained. Many research efforts have been
expended to realise this idea, however, the results obtained were
unsatisfactory due to fundamental limitations. It has been
intensively debated whether or not it would be possible to
measure the charge redistribution that is characteristic for an
antibody–antigen affinity binding with an ISFET.59,146–148 In
principle, under ideal conditions the ImmunoFET is at least
theoretically capable of measuring the concentration of im-
munomolecules with a very low detection limit and a wide
concentration range of 1027–10211 M with about a 10 mV
response signal.59 Ideal conditions that are required in this
coherence are: a truly capacitive interface at which the
immunological binding sites can be immobilised; a nearly
complete antibody coverage; highly charged antigens and a very
low ionic strength. However, the principal practical problem is
to transduce the molecular recognition action between an
antibody and an antigen into a measurable signal. It is obvious
that the potential (charge) distribution in the immediate vicinity
of the interface plays a critical role in transferring an
immunological signal to the ISFET.
Fig. 7 illustrates this situation. The potential distribution at
the electrolyte–ImmunoFET interface with immobilised anti-
body molecules in high and low ionic strength solutions is
shown schematically. It can be seen that only potential (or
charge density) changes which occur within the order of the
Debye length d can be detected. Coupling of proteins to the
surface of an ISFET within this distance has not been, however,
a realistic possibility so far.148 Dimensions of macromolecules,
like antibodies, are much longer (ca. 10 nm) than those of the
double layer (ca. 1 nm in a physiological-type solution) at the
electrolyte–insulator interface. As a consequence, in such a case
the protein charge will be at a distance greater from the surface
than the Debye length [Fig. 7(a)] and thus, will be shielded by
counter ions. The certain overlapping of potentials [Fig. 7(b)],
consequently a measurable effect with an ImmunoFET can only
be obtained in solutions with low ionic strength ( < 1022–1023
M).
An extensive critical evaluation of early works related to
potentiometric immunosensors, in particular ImmunoFETs, is
given in ref. 148 where the Donnan theory is used as a possible
explanation for the observed results. Nowadays, it is generally
accepted that screening of protein charges by small inorganic
counter ions present in the solution results in macroscopically
uncharged layers and prevents successful measurements of
immunospecies.40
To overcome the above described difficulties of a direct
detection of immunological reaction with ISFETs in a static
measurement set-up, some dynamic measurement methods
have been developed.40 The net charge density in a protein layer
immobilised in a membrane on an ISFET can be measured by
exposing the membrane to a stepwise (ion-step) change in the
electrolyte concentration. The ‘ion-step’ method was used to
determine e.g. the heparin concentration with a Ta2O5-gate
ISFET possessing an immobilised monolayer of protamine as
an affinity ligand for heparin.149 Alternatively, the acid–base
properties of proteins can be used as transducing parameters for
ISFET-based immunosensors.150–152 If the affinity binding of a
substance to a protein, immobilised in a membrane, results in a
significant change of this behaviour, the detection of this change
enables the construction of a new type of biosensor. The
required measurement principles for this can rely on coulo-
metric titrant generation, pH-step titration and ion-step meth-
Fig. 6 Schematic structure of an ImmunoFET with immobilised antibody
(Ab) molecules. Ag, antigen molecules.
Fig. 7 Schematic presentation of the potential distribution in an
electrolyte/ImmunoFET structure as a function of the distance from the
gate-insulator surface by high (a) and low (b) ionic strength. d, Debye
length; dAb, dimension of macromolecule (e.g., antibody).
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ods.151,152 As an example, the lysozyme concentration was
measured by means of the pH-step method in the concentration
range from 3 3 1027 to 3 3 1024 M.151 Another approach is
proposed153,154 where the authors have demonstrated the
feasibility of an ISFET-based immunosensor using the stream-
ing potential (or zeta potential) measurement set-up.
A further approach is the employment of an ImmunoFET in
an impedance-measurement configuration. In contrast to the
former described direct voltage or direct current behaviour,
respectively, the alternating current behaviour of an ISFET is
much more influenced by the presence of an additional protein
layer.155 Recently, the impedance spectroscopy method was
used156 to characterise immobilised protein layers on the gate of
an ISFET and to detect the antigen–antibody binding reaction.
The output signal of the developed dinitrophenyl antigen-
modified ISFET at different concentrations of dinitrophehyl
antibody have been measured as a frequency of 30 kHz. The
sensitivity of about 22 mV per decade was achieved in the linear
range of antibody concentration from 1 to 100 ng ml21.
Generally, it can be concluded that, in fact, the practical
development of an ImmunoFET for the direct detection of
immunological molecules appears to be more difficult than
originally expected. The theoretical basis of the sometimes
observed results still remains unclear. Much more theoretical
(modelling) and experimental research have to be done in order
to understand and interpret ImmunoFET measurements.
3.3. GenFET
In recent years, the rapid progress of the Human Genome
Project has stimulated the development of so-called geno-
sensors and DNA chip technology, which draw upon the
building blocks of genetics, i.e. DNA and RNA (ribonucleic
acid), as biorecognition elements. These devices offer a new
approach for fast, simple and inexpensive analysis of nucleic
acid samples with tremendous possibilities for practical applica-
tions in various fields such as the diagnosis of genetic diseases,
the detection of infectious agents, drug screening, etc. For
instance, currently about 400 diseases are diagnosable by
molecular analysis of nucleic acids, and this number is
increasing daily.157
Most of the DNA detection techniques are based on a DNA
hybridisation process. In DNA hybridisation, the target (un-
known single-stranded DNA (ssDNA)) is identified by a probe
molecule with which it forms a double-stranded (dsDNA) helix
structure with its complementary nucleic acid with high
efficiency and specificity in the presence of a mixture of many
different non-complementary nucleic acids. The unique com-
plementary nature of the base pairing, i.e. adenine–thymine and
cytosine–guanine, is the basis for the extremely high specificity
of the biorecognition process. In the literature, different
approaches for genosensors using different types of transducer
principles, like cyclic voltammetry, chronopotentiometry, ca-
pacitive, impedimetric and semiconductor field-effect princi-
ples, etc., have been described. For details, readers are referred
to reviews of recent efforts in the field of genosensors and DNA
chips.157–164
A DNA-modified FET or GenFET, schematically shown in
Fig. 8, can also be very useful for hybridisation detection. A
GenFET can be obtained by immobilising well-defined se-
quences of ssDNA onto a transducer, which converts the
specific recognition process of two DNA single strands through
the hybridisation event into a measurable signal. The inherent
miniaturisation of such devices and their compatibility with
advanced microfabrication technology can make them very
attractive for DNA diagnostics. Unfortunately, there are only a
few publications that are related to ISFETs for DNA sensing.
For example, ISFETs have been used for the sequence-selective
detection of PCR (polymerase chain reaction) products.165–167
However, for the development of fast, single, inexpensive and
disposable genosensors, direct label-free methods of hybrid-
isation detection are needed. To our knowledge, a first and only
successful attempt in the direct detection of a hybridisation
event with a GenFET was reported by Souteyrand et al. in
1997.83 Non-complex synthetic single strands of homo-oligo-
mers have been chosen as a model system to demonstrate the
feasibility of using an ISFET for the detection of a DNA
hybridisation event. Therefore, homo-oligomers either 20
(dT)20 or of the order of 1000 thymine bases (poly(dT)) were
immobilised on the previously modified SiO2-gate of an ISFET.
To detect the hybridisation process in real time, in situ
measurements were performed by adding a certain volume of
the complementary DNA (synthetic homo-oligomer single
strands (dA)18 or poly(dA) ( ~ 1000 bases)) solution directly to
the buffered electrolyte. The denaturisation was performed by
immersing the sensor in boiling, deionised water for 0.5 h.
Fig. 9 shows the response of a GenFET to successive
additions of poly(dA). A direct dependence on the quantity of
poly(dA) added was achieved. The authors conclude that the
observed changes of the gate voltage of the GenFET during the
hybridisation process can be seen as a result of the surface
charge change. These results are in good agreement with flat-
band potential shifts measured with DNA-modified EIS
(electrolyte-insulator-semiconductor) structures.168–170 At the
same time, there were discussions171 that EIS-based geno-
sensors consisting of a Si-SiO2-Si3N4 structure, were not
sufficiently sensitive enough to detect hybridisation events. The
hybridisation detection was only possible with mechanically
degraded EIS structures, i.e., a part of the dielectric area was
removed by scratching it with a diamond scribe.
Today, there are still insufficient experimental results on the
basis of GenFETs for clearly understand their functioning. Let
us believe that this situation will improve in the near future and
much effort will be directed towards new experiments with
GenFETs and the development of theoretical models, which can
Fig. 8 Schematic structure of a DNA-FET (GenFET) and the principle of DNA-hybridisation detection.
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explain the experimental results. In this context, we would like
to note the following: since DNA molecules are charged
macromolecules, and since the direct hybridisation event is an
affinity binding process, the practical realisation of a GenFET
can yield the same problems as in the case of ImmunoFETs, i.e.
the screening of macromolecule charges by small inorganic
counter ions present in the solution (see section 3.2). In our
opinion, however, in the case of the GenFET, there are some
positive factors which can promote a successful measurement of
a direct DNA hybridisation event.
These factors are as follows: (1) The unique structure of DNA
molecules. DNA is, indeed, a poly-anion with negative charges
along its phosphate backbone. It can be considered as a circular
cylinder (with a diameter of about 1.5–2 nm) with electrostatic
charges evenly distributed about the cylindrical surface;172 the
length of a DNA probe depends on the number of nucleotides
(to selectively recognise a unique human DNA sequence, DNA
probes must be at least 16 bases long159). In the test solution,
these negative charges are neutralised by positive inorganic
counter ions. Since the length of a nucleotide (or base) is about
~ 0.34 nm,48 the charge redistribution on the interface electro-
lyte/sensor resulting from the hybridisation process can be
possible even in physiological solutions (with a double layer of
about ~ 1 nm).
(2) Immobilisation of ssDNA by electrostatic attraction
between the positively charged transducer surface and the
negatively charged sugar–phosphate backbone with the bases
oriented towards the solution.173 Also, in this case, the
hybridisation process can effectively influence the distribution
of the charge density in the double layer.
(3) The charged state of the surface on which ssDNA are
immobilised. The thermodynamic theoretical analysis pre-
sented in174 shows that surface electrostatics of the substrate
(i.e., negative or positive surface potential) drastically affect the
DNA immobilisation and hybridisation process with the
possibility of a DNA hybridisation control by regulation of the
surface charge (potential). Thus, the construction of a GenFET
with positive surface potential could be more attractive.
3.4. Cell-based BioFET
In this section, cell-based BioFETs, where the smallest self-
sustaining biological entity, whole cells, are used as a
recognition element, will be discussed. A ‘cell–transistor’
hybrid is obtained by direct coupling of a single cell or cell
system to the gate insulator of a FET. Fig. 10(a) shows the
schematic of a ‘cell–transistor’ hybrid and Fig 10(b) shows the
videomicroscopic photo of genetically modified HEK 293 cells
on an ISFET array (in the centre of the photo one cell
completely covers the sensitive gate area of the ISFET).
For uniformity, in this article, we will use the term cell-based
BioFET for both cell metabolism detection and extracellular
potential measurement. For the electrogenic cell–transistor
hybrid the terms neuron-transistor81,175 or cell potential FET
(CPFET)176,177 have also often been used to emphasize the pure
extracellular potential measurements, although the gate in-
sulator used (normally SiO2 or Si3N4) is pH- or ion-sensitive,
too.
Cells are highly organised living microstructures containing
a high concentration of chemicals, including enzymes, nucleic
acids, ions, many types of proteins and small organic molecules.
They process multiple incoming information signals by means
of a parallel activation of different signalling pathways and
respond with an appropriate reaction pattern according to the
type of input physical or chemical stimulus. In spite of the many
difficulties and complications involved in using whole cells,
including their limited lifespan, the most important reason for
developing cell-based biosensors is that only by using living
components capable of a direct response to incoming informa-
tion can the effect of an external physical or chemical stimulus
on a living system be investigated.52,178,179 This functional
information with additional qualitative and/or quantitative
analytical information can be very important with respect to
clinical diagnostics, pharmacology and drug screening, cell
biology, toxicology and environmental monitoring. By means
of such biosensors, it could be possible to study the effects of
pharmaceutical compounds, toxic substances, pollutants, etc.,
on a physiological system and in particular on cellular
metabolism.
The state of a single cell or cell system can be monitored by
means of various methods, which can be distinguished into two
basic families.178 The first family of methods utilises the energy
metabolism of cells and, in principle, can be extended to all cell
types. It is sensitive to a wide range of cellular events, like
Fig. 9 Response of a GenFET to successive additions of the synthetic
homo-oligomer poly(dA).83
Fig. 10 ‘Cell–transistor’ hybrid: (a) schematic set-up; (b) videomicro-
scopic photo of genetically modified HEK 293 cells on an ISFET array
(unpublished photo, with kind permission of H. Ecken). In the centre of the
photo one cell completely covers the sensitive gate area of the ISFET.
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growth, toxicity, etc. For example, mammalian cells constantly
consume energy for synthesis of biological molecules, main-
taining gradients of ionic concentration across the cell mem-
brane, mechanical motion and for a variety of purposes. Fig. 11
shows the typical metabolic pathways, which lead to ex-
tracellular acidification.180 Signal parameters such as changes
in the extracellular pH, the concentration of ions, oxygen
consumption, CO2 production, the redox potential and other
metabolic products (e.g., glucose and lactate) can be measured
by various well-established ISFET-based single chemical
sensors and biosensors, or multi-parameter sensor systems.
Bergveld first employed the SiO2-gate ISFET for the ex-
tracellular ion-concentration measurement.181 More recently,
cell-based BioFETs with Si3N4 or Al2O3 as pH-sensitive gate
insulators have been realised for extracellular acidification as
well as for respiration (oxygen consumption) measure-
ments.176,177,182–188
The principle of the extracellular acidification measurement
with a cell-based BioFET can be briefly described as follows:
usually, the measurements of the acidification rate are per-
formed in a flow-through chamber with an array of cell-based
BioFETs, operated in the flow-stop mode. Under steady-state
conditions (pump on), one cell (approximately 105–106 cells
can be cultivated on a sensor chip) produces about ~ 108
protons per second. After an external receptor stimulation this
quantity of protons will be raised to between 10 and 100%
depending on the cell type, the receptor and the coupling
pathway.180 When the pump is stopped, the produced protons
accumulate and acidify the extracellular medium. Thus,
changes in the extracellular acidification rate caused by
different external stimuli (e.g., by addition of drugs or toxic
agents to the medium) can be detected by the underlying pH-
sensitive ISFET. In order to obtain a high sensitivity, a very
small chamber volume (usually in ml range) is required. In
principle, the ISFET can also be capable of detecting the rate of
acidification from a single cell. The main remaining technical
problem, however, is the need for confining the produced
protons to a given small volume.
Because cells respond to external stimuli with a parallel
activation of different signalling pathways (see Fig. 11), the
measurement of only one integral parameter such as the
acidification rate, is often insufficient for a clear interpretation
of different effects on living cells. Therefore, the on-line,
parallel and non-invasive measurement of different parameters
is very helpful. The so-called PhysicoControl Microsystem
(PCM) and Cell Monitoring System (CMS), which combine
different microsensors, including arrays of pH ISFETs and
CPFETs with different gate areas (from a few mm2 for single
cell measurement up to 6000 mm2 for cell population) and with
different gate materials (SiO2, SiO2–Si3N4 and SiO2–Al2O3
double layer) have been developed.176,177,185,186 Moreover,
recently the feasibility of simultaneous measurement of both the
acidification and the respiration (oxygen consumption) at the
same site in a cell culture by using a single cell-based BioFET
configuration with a surrounding noble metal electrode for
oxygen reduction and OH2 ion generation, has been demon-
strated.187 A similar, completely automated cell monitoring
microsystem, combining an array of 12 ISFETs, temperature
sensor and conductivity sensor, is described in ref. 188
In comparison to the commercially available Cytosensor
Microphysiometer system (Molecular Devices Corp.) for
cellular acidification measurement,180 which is based on a
LAPS (light-addressable potentiometric sensor), the advantages
of a cell-based BioFET system are the further miniaturisation
potential by integrating the ISFETs with other semiconductor
microsensors together with the sensor electronics on one single
sensor chip. Such a set-up guarantees statistically reliable
results by using an array of cell-based BioFETs and also the
possibility to combine this system together with a light
microscope for optical imaging.177 On the other hand, the LAPS
are simpler in fabrication.182 The possible scientific applica-
tions of such a system concern all aspects of metabolism-
affecting pathways, while commercial aspects mainly concern
pharmacological and toxicological questions.183,185,186,189
The second family of cellular measurement methods mostly
utilises specific features of certain types of electrogenic cells
such as neuronal cells, muscle cells or cell networks and include
extracellular and intracellular potential measurements. The first
attempt to apply an ISFET in neurophysiological measurements
was made in 1970.18 An ISFET was also chosen to record the
extracellular voltage from muscle tissues,190 and FET arrays
with ‘floating’ gold-gate have been used to record potential
changes of neuronal slices.80 More recently, the first recording
from single invertebrate neurons81 and vertebrate neurons191 as
well as cardiac myocyte monolayers192 cultered on the gate
insulator of a FET was reported (see also the review, 179).
Electrogenic cells generate spontaneous or triggered action
potentials (transient changes of their membrane potentials) that
can be measured by a ‘neuron–FET’ hybrid. With the help of an
additional insulated spot of silicon, a capacitive extracellular
stimulation of an individual neuron was demonstrated to be
possible193 and even a bi-directional interface between neuron
and transistor has been developed.194 This interface facilitates
both a capacitive stimulation and a capacitive recording of the
neural activity of cells cultured onto the gate of an ISFET.
Different approaches have been proposed that describe the
signal transfer from electrogenic cells to a FET and explain the
recorded signal behaviour (shape and amplitude). A commonly
used approach is the point contact model.179,192 For the
interpretation of some effects (for instance, a high ionic
conductance in the cleft between cell and transistor, the time
delay of the extracellular signal, etc.) which are observed in the
experiments with neuronal cells, different extended models
have also been reported.192,195,196 However, all these models
ignore the pH- and/or certain ion-sensitive properties of the gate
insulator (usually SiO2 or Si3N4) that can also be a source of
interfacial potential changes in the region of the neuron
adhesion, and thus, can play a major role in the coupling
behaviour of cells to the FET and consequently, in the recording
signal. This fact was already mentioned by Bergveld181 and
Grattarola.197 Recently, it was also reported by Fromherz198
that a change of local potassium concentration within the
narrow gap between cell and transistor ( ~ 50 nm) during
channel activation may also modulate the electrical double layer
in front of the gate oxide and affect the transistor. It seems that
the ideas and experience in the field of the development of a
Fig. 11 The cell biology of extracellular acidification: upon receptor
stimulation, signal transduction pathways are induced. The corresponding
ATP consumption is compensated by the increased uptake and metabolism
of glucose, which results in an increase in the excretion of acid waste
products. The extracellular acidification can be measured by field-effect
sensors (e.g., LAPS or ISFET).180
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reference FET (see e.g., ref. 60), for example, by using thin
polymer films with a very small amount of surface active sites
( ~ 1012 cm22), which possess very low pH- and/or ion-
sensitivity properties, can also be very useful in understanding
these phenomena in more detail.
The coupling strength between a neuron and a micro-
electronic chip, i.e. the adhesion ‘quality’ of neurons to the
transducer surface is the most critical parameter that may
seriously change the features of the recorded extracellular
signals. Therefore, the determination of the width of the cleft
and the measurement of the specific resistance in the region of
adhesion were attempted.199 It was found that the specific
resistance in the cleft is a factor 4 larger than the specific
resistance of the bulk electrolyte.199 The issues of cell
attachment and growth on a modified microelectronic device
surface,200 on silicon nanostructures,201 on microperforated
silicon membranes202 as well as on 3-dimensionally micro-
structured silicon wafers (grooves and square wells with
different dimensions)203 have also been studied.
In addition to neuronal cells, cardiac muscle cells represent
an interesting electrically active system that processes bio-
logical information. The spontaneous rhythmic electrical and
mechanical activity of cultered myocardiac cells is widely used
in the study of cardiac physiology. Their beating frequency can
be changed with cardiac stimulants and relaxants. Recently, the
electrical recording from rat cardiac muscle cells using a
bioelectronic device, which consists of an array of 16 FETs (for
the technological detail see ref. 204), have been reported. A
long-term and multisite recording system for monitoring
electrogenic cells in culture have been discussed, too.205 As an
example, Fig. 12 shows the electrical recording signal from
cardiac myocytes. For comparison, the measurements were
simultaneously performed both extracellularly using a FET
(lower curve) and intracellularly using a microelectrode (upper
curve). Furtheremore, this system was adapted for recording the
effects of different drugs (cardiac stimulants and relaxants) on
cardiac myocytes.206,207 The change in the beat frequency of
heart cells in the presence of norepinephrine and isoproterenol
shows a distinct concentration dependence between 0.01 and 10
mM. These results demonstrate the potential of a cell–transistor
hybrid system for drug testing applications.
Finally, neuronal cell networks coupled with FET networks
are also perspective candidates for both fundamental study of
signal transduction and propogation between interconnected
cells, and for pharmacological and toxicological applications.
The aim is mainly to create a 2-dimensional communication
between the cells and microelectronic transducers. Recent
attempts in this field show the possibility of creation of small
neural networks using micro-contact printing 208,209 or litho-
graphic technology.210 However, progress in this field will
depend on a successful solution of some problems concerning
the technological realisation of large networks, the signal-to-
noise ratio, the large amount of data which needs to be
processed as well as the lack of a clear understanding of the
complex neuronal networks response.
3.5. ‘Beetle/chip’ FET
Taking whole animals or at least complete sensory organs (e.g.,
insect antenna) as a biological recognition element comprises a
new trend in bioelectronic sensor development, although this
idea was introduced by Rechnitz in 1986.211 For example,
insects are known for their specially developed sense of smell.
Among the approximately one million insect species, only
about 250 have been tested for their olfactory abilities so far.
About 250 pheromones and about 400 host plant odours are
known that can be detected with extremely high sensitivity and
selectivity using these unique features of insects.
A design to couple an insect antenna directly to a FET,
thereby creating a completely new type of biosensor, a so-called
‘beetle/chip’ sensor, was first realised82 and then investigated in
detail and optimised.212–220 In this approach, the voltage
generated in the antenna upon detecting a certain odour is used
to modify the drain current of the transitor. The responsible
organ for smell, i.e. the insect antenna, usually consists of
several segments, equipped with small hairs, the so-called
sensilla, which contain the olfactory receptor neurons. The
odour recognition process is initiated at the nerve cell
membranes. As a result of odour stimulation, an odour
concentration-dependent voltage pulse is generated over the
whole antenna yielding a dipole that leads to respective peaks in
the drain current of the FET. For details of the odour-detection
mechanism of the ‘beetle/chip’ sensor see refs 215, 217 and
221.
In order to measure the signals generated in the insect
antenna, a bioelectronic interface has to be established between
the insect antenna and the FET. Generally, there are two
possible configurations of coupling the antenna to the FET.213
The first configuration is a whole beetle BioFET, where the
whole beetle is fixed in a cell and the tip of the insect antenna
is dipped into an electrolyte solution that is in direct contact with
the gate insulator of the FET as schematically shown in Fig.
13(a). A reference electrode, e.g. platinum wire, has then to be
placed into an appropriate site of the beetle, e.g. between the
neck and the head. In the second configuration, the isolated
antenna BioFET, the antenna is dissected from the beetle and
contacted on both sides with the electrolyte solution (Fig.
13(b)). If now an air current, loaded with a marker compound is
flushed over the antenna (set-up (a) or (b)), the induced
depolarisation response will modify the conductance of the FET
channel between source and drain, yielding a change in the drain
current as sensor signal.
As an example, Fig. 14(a) presents a typical dose–response
curve of the ‘beetle/chip’ sensor with the antenna of a Colorado
potato beetle. The odour pulses are different concentrations of
the specific green-leaf odour cis-3-hexen-1-ol in air from 1 ppt
to 100 ppm. As can be seen, the peak size of the sensor response
clearly depends on the respective odour quantity. The more
intense the odour stimulus for the antenna, the higher the
recorded signal. The sensor signal is given by drain-current
changes in the mA range. In this experiment, the measurements
were performed using a specific sensor head with antenna
holder and a BioFET-based sensor system, which provides a
stream of air with constant temperature, humidity and velocity
as well as the injection of the respective odour pulses.214,220
This BioFET-based ‘beetle/chip’ sensor enables the detection of
odour concentrations down to the ppt concentration range (Fig.
14(b)).219 The signal-to-noise ratio of the ‘beetle/chip’ FET was
improved by choosing an appropriate gate layout214 and the
biological receptor part of the sensor, i.e. the insect antenna, was
characterised by means of impedance spectroscopy in order to
Fig. 12 Intracellular (upper curve, with microelectrode) and extracellular
(lower curve, with FET) recording of cardiomyocytes.205
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obtain information about the electrical behaviour of the
antenna.217
One interesting application of the developed ‘beetle/chip’
sensor is in the detection of plant damage in potato fields in
order to determine the right timing for pesticide application. For
example, thousands of potato fields annually fall prey to the
potato beetle. As a consequence, many farmers spray large
quantities of pesticides that mainly save the harvest, but
simultaneously contaminate the soil and groundwater and kill
useful insects. By means of the developed bioelectronic device,
a field’s infestation with beetles could be identified at an early
stage. Another application might be in an early fire alarm
system: smouldering fires such a burning coal, paper and wood,
can be detected by means of monitoring fire-specific odours
(e.g., guaicol and 1-octen) using the same biosensor only with
the antenna of a steelblue jewel beetle instead.215,219
At present, the ‘beetle/chip’ biosensor is still at the
development stage but it shows great promise for the future. The
possible field of applications can be extended by employing
various insect species with different sensitivity profiles. There-
fore, it is of value to construct a library of beetle species with
their odour detection spectra.
4 Conclusion and perspectives
Thirty years have elapsed since the invention of the ISFET by
Bergveld. Since that time, various types of BioFETs have been
developed using different biological recognition elements
starting with enzymes and immunological species through DNA
molecules to living cells and even living organisms. The study
of the current state of BioFETs reveals that some BioFETs, like
EnFETs are at a well-developed stage, whereas other BioFETs
such as GenFETs and ‘beetle/chip’ FETs are in the initial stages
of development. There are still a number of fundamental and
technological problems that must be overcome, before the first
reliable BioFET-based bioanalytical microsystem will appear
on the market. Therefore, intensive interdisciplinary research
and cooperation of specialists from different disciplines is still
required, not only in the field of biotechnology and bioengineer-
ing but also in related disciplines, like informatics, solid-state
physics, microtechnology, genetics as well as specific tech-
niques such as sensor integration and packaging, interfacing
circuits, etc.
Hence, future prospects for BioFET developments can be
expected in the following directions: (i) BioFETs utilising intact
biological receptors (ion channel receptors, binding proteins,
etc.) that bind specific drugs and reagents in such a way that
they produce a conformational change in the protein structure.
This conformational change, in turns, triggers a cellular
response, (e.g., the opening of an ion channel of the membrane
(so-called ion-channel switch biosensor); (ii) ISFET-based
DNA chips can be considered as a new tool for the simultaneous
analysis of thousands of nucleic acids with a broad area of
potential applications in biomedical research and clinical
diagnostics, genomics, drug screening, environmental monitor-
ing and food industry. They combine both the possibility of
direct DNA hybridisation detection without the use of labelled
probes and the large integration ability of these active
microelectronic devices (high density arrays of active areas up
to 105 cm22 can be achieved); (iii) The creation of large
neuronal networks on a CPFET array and thus, a better
understanding of ‘in-situ’ complex neurobiological responses
of neuronal networks, which can open up new avenues for, (e.g.,
drug screening; and (iv) The integration of BioFETs in
bioanalytical microsystems, including other chemical and
physical sensors, actuators as well as fluidic components. The
recently developed concept of a combination of (bio-)chemical
and physical sensors using an identical transducer princi-
ple111,222 can serve to be an innovative way to create cost-
effective modules for bioanalytical microsystems.
The listed examples appear to be incomplete, since at least 10
new ideas and concepts in the field of BioFETs are submitted in
different scientific journals during the writing of this review.
But this fact emphasizes the exciting nature of the subject.
Fig. 13 Two general configurations of coupling an insect antenna as
biorecognition component to a FET: (a) ‘whole-beetle’ BioFET and (b)
‘isolated-antenna’ BioFET. The antenna is highly sensitive towards
different odour concentrations.
Fig. 14 Typical dose–response curve of the ‘beetle/chip’ sensor with the
antenna of a Colorado potato beetle towards odour pulses of different
concentrations of the green-leaf odour, cis-3-hexen-1-ol, in air (a) and list of
detectable odour substances with their respective concentration ranges (b).
The increasing number of ‘+’ indicates the higher sensitivity.
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Consequently, in the near future, a multitude of interesting
experiments and results will accompany the development of
BioFETs.
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